An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteriaOACSTPCDMEDLINE
An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria
Lincheng Zhang;Wei Zhou;Shusen Zheng;Sunbin Ling;Xiao Xu
Zhejiang University School of Medicine,Hangzhou,Zhejiang 310058,ChinaShulan(Hangzhou)Hospital,Zhejiang Shuren University School of Medicine,Hangzhou,Zhejiang 310022,China||Department of Hepatobiliary and Pancreatic Surgery,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang 310003,China||National Center for Healthcare Quality Management in Liver Transplant,Hangzhou,Zhejiang 310003,ChinaZhejiang University School of Medicine,Hangzhou,Zhejiang 310058,China||Department of Hepatobiliary and Pancreatic Surgery,Hangzhou First People's Hospital,Hangzhou,Zhejiang 310006,ChinaZhejiang University School of Medicine,Hangzhou,Zhejiang 310058,China||National Center for Healthcare Quality Management in Liver Transplant,Hangzhou,Zhejiang 310003,China||School of Clinical Medicine,Hangzhou Medical College,Hangzhou,Zhejiang 310014,China
《中华医学杂志（英文版）》 2024 (016)
1973-1975 / 3
The study was supported by grants from the National Natural Science Foundation of China(Nos.92159202,82273270,and 32171368)and National Science and Tech-nology Major Project of China(No.2017ZX10203205).
评论